Literature DB >> 28126957

Parsing the repertoire of GPIb-IX-V disorders.

A Koneti Rao1, Natthapol Songdej1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28126957      PMCID： PMC5270391          DOI： 10.1182/blood-2016-12-753186

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Glycoprotein Ibalpha forms disulfide bonds with 2 glycoprotein Ibbeta subunits in the resting platelet.

Authors:  Shi-Zhong Luo; Xi Mo; Vahid Afshar-Kharghan; Sankaranarayanan Srinivasan; José A López; Renhao Li
Journal:  Blood       Date:  2006-09-28       Impact factor: 22.113

2.  Inherited thrombocytopenias: the beat goes on.

Authors:  A Koneti Rao; Natthapol Songdej
Journal:  Blood       Date:  2015-01-29       Impact factor: 22.113

3.  Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome.

Authors:  A Savoia; C L Balduini; M Savino; P Noris; M Del Vecchio; S Perrotta; S Belletti; A Iolascon
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

4.  Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex.

Authors:  L De Marco; M Mazzucato; F Fabris; D De Roia; P Coser; A Girolami; V Vicente; Z M Ruggeri
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

Review 5.  Spectrum of the mutations in Bernard-Soulier syndrome.

Authors:  Anna Savoia; Shinji Kunishima; Daniela De Rocco; Barbara Zieger; Margaret L Rand; Nuria Pujol-Moix; Umran Caliskan; Huseyin Tokgoz; Alessandro Pecci; Patrizia Noris; Alok Srivastava; Christopher Ward; Marie-Christine Morel-Kopp; Marie-Christine Alessi; Sylvia Bellucci; Philippe Beurrier; Emmanuel de Maistre; Rémi Favier; Nathalie Hézard; Marie-Françoise Hurtaud-Roux; Véronique Latger-Cannard; Cécile Lavenu-Bombled; Valérie Proulle; Sandrine Meunier; Claude Négrier; Alan Nurden; Hanitra Randrianaivo; Fabrizio Fabris; Helen Platokouki; Nurit Rosenberg; Basma HadjKacem; Paula G Heller; Mehran Karimi; Carlo L Balduini; Annalisa Pastore; Francois Lanza
Journal:  Hum Mutat       Date:  2014-07-15       Impact factor: 4.878

Review 6.  Inherited disorders of platelets: membrane glycoprotein disorders.

Authors:  Reyhan Diz-Kücükkaya; José A López
Journal:  Hematol Oncol Clin North Am       Date:  2013-06       Impact factor: 3.722

7.  Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopenia.

Authors:  Suthesh Sivapalaratnam; Sarah K Westbury; Jonathan C Stephens; Daniel Greene; Kate Downes; Anne M Kelly; Claire Lentaigne; William J Astle; Eric G Huizinga; Paquita Nurden; Sofia Papadia; Kathelijne Peerlinck; Christopher J Penkett; David J Perry; Catherine Roughley; Ilenia Simeoni; Kathleen Stirrups; Daniel P Hart; R Campbell Tait; Andrew D Mumford; Michael A Laffan; Kathleen Freson; Willem H Ouwehand; Shinji Kunishima; Ernest Turro
Journal:  Blood       Date:  2016-11-14       Impact factor: 22.113

Review 8.  Lessons in platelet production from inherited thrombocytopenias.

Authors:  Alessandro Pecci; Carlo L Balduini
Journal:  Br J Haematol       Date:  2014-01-30       Impact factor: 6.998

Review 9.  Inherited platelet disorders: toward DNA-based diagnosis.

Authors:  Claire Lentaigne; Kathleen Freson; Michael A Laffan; Ernest Turro; Willem H Ouwehand
Journal:  Blood       Date:  2016-04-19       Impact factor: 25.476

10.  Platelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: a multicentric, real life study.

Authors:  Patrizia Noris; Catherine Klersy; Paolo Gresele; Fiorina Giona; Paola Giordano; Pietro Minuz; Giuseppe Loffredo; Alessandro Pecci; Federica Melazzini; Elisa Civaschi; Annamaria Mezzasoma; Monica Piedimonte; Fabrizio Semeraro; Dino Veneri; Francesco Menna; Laura Ciardelli; Carlo L Balduini
Journal:  Br J Haematol       Date:  2013-04-25       Impact factor: 6.998
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.